Data timelines which jump out from this announcement.
Azer-cel: Allogeneic CAR T cell therapy
- A preliminary early data update is anticipated in the second half of 2024
VAXINIA MAST Trial
- Bile tract cancer expansion trial opened and is expected to enroll approximately 10 patients; preliminary early data is expected in the second half 2024
OnCARlytics (CF33-CD19)
- Preliminary early combination data are expected in the fourth quarter of 2024
B Cell Immunotherapy: PD1-Vaxx
- Preliminary early data are expected in 2025
Good luck to all holders brave enough to have invested patient capital.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Data timelines which jump out from this announcement.Azer-cel:...
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $505.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50724 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50724 | 0.075 |
2 | 40395 | 0.071 |
5 | 830281 | 0.070 |
14 | 4701895 | 0.069 |
25 | 2170079 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 9000 | 1 |
0.069 | 15000 | 1 |
0.070 | 389049 | 8 |
0.071 | 989423 | 7 |
0.072 | 751892 | 10 |
Last trade - 09.42am 21/05/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
Day chart unavailable